- § 52e.1 - To what programs do these regulations apply?
- § 52e.2 - Definitions.
- § 52e.3 - Who is eligible to apply?
- § 52e.4 - How to apply.
- § 52e.5 - What are the project requirements?
- § 52e.6 - How will NIH evaluate applications?
- § 52e.7 - What are the terms and conditions of awards?
- § 52e.8 - Other HHS regulations and policies that apply.
- § 52e.9 - Additional conditions.
§ 52e.1 - To what programs do these regulations apply?
(a) This part applies to grants under section 419 of the Act (42 U.S.C. 285b-1) for projects to:
(1) Demonstrate and evaluate the effectiveness of new techniques or procedures for the prevention and control of heart, blood vessel, lung, and blood diseases, with special consideration given to the prevention and control of these diseases in children, and in populations that are at increased risk with respect to such diseases;
(2) Develop and evaluate methods of educating health practitioners concerning the prevention and control of these diseases; and
(3) Develop and evaluate methods of educating the public concerning the prevention and control of these diseases.
(b) For purposes of this part, prevention and control projects shall include community-based and population-based programs carried out in cooperation with other Federal agencies, with public health agencies of State or local governments, with nonprofit private entities that are community-based health agencies, or with other appropriate public or nonprofit private entities.
§ 52e.2 - Definitions.
As used in this part:
Act means the Public Health Service Act, as amended (42 U.S.C. 201 et seq.).
Council means the National Heart, Lung, and Blood Advisory Council, established under section 406 of the Act (42 U.S.C. 284a).
Director means the Director of the National Heart, Lung, and Blood Institute and any official to whom the authority involved may be delegated.
Emergency medical services means the services utilized in responding to the perceived individual need for immediate medical care in order to prevent loss of life or aggravation of physiological or psychological illness or injury.
HHS means the Department of Health and Human Services.
National program means the National Heart, Blood Vessel, Lung, and Blood Diseases and Blood Resources Program referred to in section 421 of the Act (42 U.S.C. 285b-3).
Nonprofit as applied to any agency or institution means an agency or institution which is a corporation or an association, no part of the net earnings of which inures or may lawfully inure to the benefit of any private shareholder or individual.
PHS means the Public Health Service.
§ 52e.3 - Who is eligible to apply?
To be eligible for a grant under this part, an applicant must be a public or nonprofit private agency or institution.
§ 52e.4 - How to apply.
(a) Application for a grant under this subpart shall be made on an authorized form.
(b) Each private institution which does not already have on file with the National Institutes of Health evidence of nonprofit status, must submit with its application acceptable proof of such status.
(c) In addition to any other pertinent information that the Director may require each application shall set forth in detail:
(1) The nature and purpose of the proposed project and the methods to be employed in carrying it out;
(2) The relevance of the proposed project to the National Program;
(3) The defined population to participate in the proposed project and the rationale for its selection;
(4) With respect to applications relating to projects covered by § 52e.1(a)(1), prior research findings on which the proposed project is based;
(5) The personnel, facilities, and other resources, including community resources, available to carry out the proposed project;
(6) Current activities of the applicant involving prevention or control of heart, blood vessel, lung, and blood diseases, the sources of funding for such activities, and the anticipated relationship of these activities to the proposed project;
(7) The names and qualifications of the project director and key staff members who would be responsible for conducting the proposed project;
(8) Proposed methods for monitoring and evaluating the project; and
(9) The proposed project period; a detailed budget for the first budget period, including a list of other anticipated sources of support and anticipated total needs for each of the succeeding budget periods of the requested project period; and a justification for the amount of grant funds requested.
§ 52e.5 - What are the project requirements?
(a) An approvable application must demonstrate to the satisfaction of the Director that:
(1) With respect to applications relating to projects covered by § 52e.1(a)(1), the techniques or procedures to be demonstrated and evaluated have been found safe and effective in the research setting and, based upon research findings, appear to have the potential for general applicability to the prevention, diagnosis, or treatment of heart, blood vessel, lung, or blood diseases;
(2) With respect to applications relating to projects covered by § 52e.1(a)(2) and § 52e.1(a)(3), the project will include development and evaluation of one or more methods for educating health practitioners or the public concerning advances in the prevention, diagnosis, or treatment of such diseases; and
(3) The nature of the project is such that its completion may be anticipated within the project period, or such other period as may be specified in the application.
(b) The project must, in the judgment of the Director, be necessary for cooperation by the National Heart, Lung, and Blood Institute with one or more other Federal Health agencies, State, local or regional public health agencies, or nonprofit private health agencies in the diagnosis, prevention, or treatment of heart, blood vessel, lung or blood diseases.
§ 52e.6 - How will NIH evaluate applications?
(a) Within the limits of funds available, after consultation with the Council, the Director may award grants to applicants with proposed projects which in the Director's judgment will best promote the purposes of section 419 of the Act, taking into consideration among other pertinent factors:
(1) The scientific and technical merit of the proposed project;
(2) The significance of the project in relation to the goals of the National Program;
(3) Whether the project appropriately emphasizes the prevention, diagnosis, or treatment of heart, blood vessel, lung, or blood diseases of children;
(4) The qualifications and experience of the project director and other key personnel;
(5) The administrative and managerial capability and fiscal responsibility of the applicant;
(6) The reasonableness of the proposed budget in relation to the proposed project;
(7) The adequacy of the methods proposed for monitoring and evaluating the proposed project; and
(8) The degree to which the application adequately provides for the requirements set forth in §§ 52e.5(a) and 52e.5(b).
(b) The notice of grant award specifies how long HHS intends to support the project without requiring the project to recompete for funds. This period, called the project period, will usually be for 1-5 years.
(c) Generally, the grant will initially be for one year and subsequent continuation awards will also be for one year at a time. A grantee must submit a separate application to have the support continued for each subsequent year. Decisions regarding continuation awards and the funding level of such awards will be made after consideration of such factors as the grantee's progress and management practices, and the availability of funds. In all cases, continuation awards require a determination by HHS that continued funding is in the best interest of the government.
(d) Neither the approval of any application nor the award of any grant commits or obligates the United States in any way to make any additional, supplemental, continuation, or other award with respect to any approved application or portion of an approved application.
(e) Any funds granted under this part shall be expended solely for the purposes for which the funds were granted in accordance with the approved application and budget, the regulations of this part, the terms, and conditions of the award, and the applicable cost principles prescribed in 45 CFR part 75, subpart E.
§ 52e.7 - What are the terms and conditions of awards?
(a) Any funds granted pursuant to this part shall be expended solely for the purposes for which the funds were granted in accordance with the approved application and budget, the regulations of this part, the terms and conditions of the award, and the applicable cost principles prescribed by 45 CFR part 75, subpart E.
(b) The Director may permit unobligated grant funds remaining in the grant account at the close of a budget period to be carried forward for obligation during a subsequent budget period, provided a continuation award is made for that period and the NHLBI Director's written approval is obtained. The amount of any subsequent award will take into consideration unobligated grant funds remaining in the grant account.
§ 52e.8 - Other HHS regulations and policies that apply.
Several other regulations apply to grants under this part. These include but are not necessarily limited to:
§ 52e.9 - Additional conditions.
The Director, may with respect to any grant award impose additional conditions prior to or at the time of any award when in the Director's judgment those conditions are necessary to assure or protect advancement of the approved project, the interests of the public health, or the conservation of grant funds.